These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30979575)

  • 1. Compounded gabapentin for neuropathic pain: Stability and beyond-use date (BUD) in some commonly used bases.
    Shakshuki A; Yeung P; Agu RU
    J Am Pharm Assoc (2003); 2019; 59(4):514-520. PubMed ID: 30979575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compounded Topical Gabapentin for Neuropathic Pain: Does Choice of Base Affect Efficacy?
    Shakshuki A; Agu RU
    Int J Pharm Compd; 2019; 23(6):496-503. PubMed ID: 31751946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of Compounded Topical Nifedipine in Cream, Gel, and Ointment Bases.
    Teimouri A; Yeung P; Agu RU
    Int J Pharm Compd; 2021; 25(4):344-351. PubMed ID: 34297697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability Assessment of Topical Amitriptyline Extemporaneously Compounded with Lipoderm Base, PLO Gel Mediflo 30, and Emollient Cream.
    Shakshuki A; Agu RU
    Int J Pharm Compd; 2019; 23(1):82-87. PubMed ID: 30668540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of Compounded Diltiazem Hydrochloride in Cream, Ointment, and Gel Formulations for Topical Use.
    Teimouri A; Yeung P; Agu RU
    Int J Pharm Compd; 2020; 24(6):482-490. PubMed ID: 33217738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compounded Topical Amitriptyline for Neuropathic Pain: In Vitro Release from Compounding Bases and Potential Correlation with Clinical Efficacy.
    Shakshuki A; Yeung P; Agu RU
    Can J Hosp Pharm; 2020; 73(2):133-140. PubMed ID: 32362670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs.
    Gorman G; Sokom S; Coward L; Arnold JJ
    Int J Pharm Compd; 2017; 21(2):164-170. PubMed ID: 28346213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the chemical and physical stability of ketoprofen compounded in various pharmaceutical bases on its topical and transdermal delivery.
    Nornoo AO; Wulz J; Yoon H; Nan Y; Lese M
    Pharm Dev Technol; 2016 Mar; 21(2):204-13. PubMed ID: 25431959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability Evaluation of Bracketed Diclofenac Sodium USP in VersaPro™ Cream Base, VersaPro™ Gel Base and PLO Gel Mediflo™ 30 Compound Kit.
    Friciu M; Cull E; Haiub H; Lupatini R; Leclair G
    Int J Pharm Compd; 2024; 28(2):156-160. PubMed ID: 38604143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Percutaneous Absorption of Ketamine HCl, Gabapentin, Clonidine HCl, and Baclofen, in Compounded Transdermal Pain Formulations, Using the Franz Finite Dose Model.
    Bassani AS; Banov D
    Pain Med; 2016 Feb; 17(2):230-8. PubMed ID: 26352507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of chronic neuropathic pain with single and compounded topical analgesics.
    Knezevic NN; Tverdohleb T; Nikibin F; Knezevic I; Candido KD
    Pain Manag; 2017 Nov; 7(6):537-558. PubMed ID: 29125423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin permeation and antinociception of topical gabapentin formulations.
    Bryson E; Asbill S; Sweitzer S
    Int J Pharm Compd; 2014; 18(6):504-11. PubMed ID: 25906628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical and Chemical Stability of Estriol 0.025% to 1% Vaginal Creams (VersaBase).
    Ip K; Shan A; Yan W; Banov D
    Int J Pharm Compd; 2018; 22(6):504-511. PubMed ID: 30384351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of Two Antifungal Agents, Fluconazole and Miconazole, Compounded in HUMCO RECURA Topical Cream to Determine Beyond-Use Date.
    Gautam P; Light B; Purvis T
    Int J Pharm Compd; 2017; 21(2):154-159. PubMed ID: 28346211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of diabetic foot ulcers: a 25% lidocaine topical cream formulation design, physicochemical and microbiological assessments.
    Sadou Yayé H; Faucheron A; Dupont L; El Kouari F; Fekkar A; Bellanger A; Tilleul P
    Eur J Hosp Pharm; 2020 May; 27(3):162-167. PubMed ID: 32419937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical Stability and Release Profile of Compounded Gabapentin Containing Pluronic Lecithin Organogel for Neuropathic Pain Management.
    Hong EJ; Sumanasekera W; Le UM
    Int J Pharm Compd; 2022; 26(1):65-71. PubMed ID: 35081046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of two stable oral suspensions for gabapentin.
    Nahata MC
    Pediatr Neurol; 1999 Mar; 20(3):195-7. PubMed ID: 10207927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term stability of morphine hydrochloride in 0.9% NaCl infusion polyolefin bags after freeze-thaw treatment and in polypropylene syringes at 5 degrees C + 3 degrees C.
    Hecq JD; Godet M; Gillet P; Jamart J; Galanti L
    Int J Pharm Compd; 2014; 18(1):78-82. PubMed ID: 24881344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of compounding and storage conditions on stability of pergolide mesylate.
    Davis JL; Kirk LM; Davidson GS; Papich MG
    J Am Vet Med Assoc; 2009 Feb; 234(3):385-9. PubMed ID: 19210262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of gabapentin in extemporaneously compounded oral suspensions.
    Friciu M; Roullin VG; Leclair G
    PLoS One; 2017; 12(4):e0175208. PubMed ID: 28414771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.